ANPARIO PLC

Report Publication Announcement • Sep 9, 2025

National Storage Mechanism | Additional information

RNS Number : 6246Y

Anpario PLC

09 September 2025

Anpario plc

("Anpario" or the "Company")

Investor Presentation via Investor Meet Company

Anpario (AIM: ANP), the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is pleased to announce that Richard Edwards, CEO, and Marc Wilson, Group Finance Director, will provide a live presentation relating to the Company's Interim Results for the six months to 30 June 2025, via Investor Meet Company on 11 September 2025, at 12:30 BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 10 September 2025, at 09:00 BST, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Anpario plc via:

https://www.investormeetcompany.com/anpario-plc/register-investor

Investors who already follow Anpario plc on the Investor Meet Company platform will automatically be invited.

Enquiries

Anpario plc
Richard Edwards, Chief Executive Officer	+44(0)7776 417 129
Marc Wilson, Group Finance Director	+44(0)1909 537 380
Shore Capital
(Nominated Adviser and Broker)	+44 (0) 20 7408 4090
Stephane Auton	Corporate Advisory
David Coaten
Tom Knibbs
Henry Willcocks	Corporate Broking

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUPUWWBUPAGUB